June 18, 2020
Gelesis Announces Partnership for Commercial Launch of Plenity® in China
Partnership includes $35 million up front licensing fees and equity investment, with future milestone payments of up to $388 million…
Pharmaceuticals, Biotechnology and Life Sciences
Partnership includes $35 million up front licensing fees and equity investment, with future milestone payments of up to $388 million…
NEW YORK–(BUSINESS WIRE)–Upjohn Inc. (“Newco”), a wholly-owned subsidiary of Pfizer Inc. (“Pfizer”) (NYSE: PFE), Upjohn Finance B.V. (“Finco”), a wholly-owned…
Dexamethasone was shown to save the lives of seriously ill patients as a ground-breaking development in fight against COVID-19 Demonstrates…
DUBLIN–(BUSINESS WIRE)–The “Preterm Birth Prevention and Management Market – Global Industry Analysis and Opportunity Assessment, 2019-2029” report has been added…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Global Drug Forecast and Market Analysis to 2028” report has been added to ResearchAndMarkets.com’s offering. This…
Infectivity assays carried out in collaboration with Glasgow University show that Affimer reagents prevent infection of human cells by a…
BAAR, Switzerland–(BUSINESS WIRE)–CorFlow Therapeutics AG (“CorFlow”) announces today that Dr. Felice Gragnano, MD, Inselspital, Bern University Hospital, Bern, Switzerland, will…
LUXEMBOURG–(BUSINESS WIRE)–Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent…
— IMpassion031 data will be discussed with health authorities globally, including the U.S. Food and Drug Administration and the European…
Topline results expected early 2021 SEONGNAM, South Korea–(BUSINESS WIRE)–AriBio, a clinical-stage biopharmaceutical company based in South Korea, announced today, June…